About a million Americans have an inherited condition that defies cholesterol-lowering statins. Even at $14,600 a year, a new drug provides hope.
GINA KOLATA, NY Times: Science
Tue, 07/28/2015 - 2:29pm
About a million Americans have an inherited condition that defies cholesterol-lowering statins. Even at $14,600 a year, a new drug provides hope.